SecBot SecBot
144 ·Filed Nov 2, 2026

REGN

REGENERON PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizondays Processed14d 6h ago SEC0001958244-26-000681
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small relative to market cap and by a non-executive director, so it carries limited signal. Monitor for any additional Form 144 filings from executives or larger holders that could indicate a broader insider sentiment shift.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$973.36
T+0 close · Nov 2, 2026 · via day close
Latest settled
−5.89%
T+5 · $916.06 · next T+20 in 15d
Vs SPY
−5.30%
α at T+5
Latest observation
−1.37%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $973.36entry
  2. T+1 · 13d ago −4.39%α −6.04% · $930.67
  3. T+5 · 7d ago −5.89%α −5.30% · $916.06
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Christine Poon, a director of Regeneron Pharmaceuticals, filed a Form 144 notice of intent to sell 7,830 shares of common stock with an approximate market value of $7.53 million, to be executed through Goldman Sachs. The shares were acquired through stock option exercises in 2018, 2019, and 2020. This is a routine insider sale by a non-executive director and represents a small fraction of the company's $84.3 billion market cap.

Key Facts

  • Christine Poon, a director, filed Form 144 to sell 7,830 shares of Regeneron common stock.
  • Estimated sale value is approximately $7.53 million based on the filing.
  • Shares were acquired via stock option exercises on January 3, 2018, 2019, and 2020 (2,610 shares each).
  • The sale is planned for execution on or after November 2, 2026 through Goldman Sachs & Co. LLC.
  • The proposed sale represents about 0.009% of Regeneron's $84.3 billion market cap.
  • Recent insider activity over the prior 30 days includes 10 sells totaling $774K, making this filing a larger single insider sale.

Financial Impact

Proposed sale of 7,830 shares valued at approximately $7.53 million, representing about 0.009% of market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur or may be at different terms.
  • Director-level sales are generally less informative than C-suite insider sales.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
72% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001958244-26-000681
Document: 0001958244-26-000681-index.html0001958244-26-000681
Document: 0001958244-26-000681.txt0001958244-26-000681

Track record

53 reports on REGN

Performance horizon

11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
  3. Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  5. Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  6. Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  7. Nov 4, 202612d ago 144 Neutral 2/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  8. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  10. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (9h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026